L-type voltage-dependent calcium channel is involved in the snake venom group IA secretory phospholipase A2-induced neuronal apoptosis

NeuroToxicology

Volumn 35, Issue 1, 2013, Pages 146-153

  Yagami, Tatsurou ^a   Yamamoto, Yasuhiro ^a   Kohma, Hiromi ^a   Nakamura, Tsutomu ^a   Takasu, Nobuo ^b   Okamura, Noboru ^c  

^a HIMEJI DOKKYO UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cerebral cortex; Group IA secretory phospholipase A2; L type voltage dependent Ca2+ channel; Neurons; NMDA receptor

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 5,7 DICHLOROKYNURENIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; L TYPE VOLTAGE DEPENDENT CALCIUM CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE; SNAKE VENOM; SNAKE VENOM GROUP IA SECRETORY PHOSPHOLIPASE A2; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOCHEMISTRY; BRAIN CELL; CALCIUM TRANSPORT; CELL ASSAY; CELL SURVIVAL; CELL ULTRASTRUCTURE; CHROMATIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; EMBRYO; NAJA NAJA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; CEREBRAL CORTEX; CHROMATIN ASSEMBLY AND DISASSEMBLY; COBRA VENOMS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GROUP IA PHOSPHOLIPASES A2; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84874408844     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2012.12.009     Document Type: Article

References (22)

1. 2-induced neurotoxicity in vitro and in vivo in rats. Brain Res 1995, 693:101-111.
2. 2 in porcine cerebral cortex. J Biol Chem 1999, 274:26315-26320.
3. 2 in rat brain. Brain Res Mol Brain Res 1997, 49:120-126.
4. 2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 2006, 58:591-620.
5. 2 receptor. Biol Pharm Bull 2004, 27:1165-1167.
6. 2 receptors from various mammals. Eur J Biochem 1994, 225:375-382.
7. 2-mediated neuronal cell death involves glutamate ionotropic receptors. Neuroreport 2002, 13:1963-1966.
8. 2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures. J Biol Chem 1996, 271:32722-32728.
9. Lambeau G., Barhanin J., Schweitz H., Qar J., Lazdunski M. Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J Biol Chem 1989, 264:11503-11510.
10. 2 in skeletal muscle. J Biol Chem 1990, 265:9526-9532.
11. Liu W.H., Cheng Y.C., Chang L.S. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells. J Cell Physiol 2009, 219:642-651.
12. 2 modulate the release of arachidonic acid from neuronal membranes. J Neurosci Res 2002, 68:558-567.
13. 2+ channels: a possible involvement of free radicals. J Neurochem 1997, 68:265-271.
14. Yagami T., Takase K., Yamamoto Y., Ueda K., Takasu N., Okamura N., et al. Fibroblast growth factor 2 induces apoptosis in the early primary culture of rat cortical neurons. Exp Cell Res 2006, 316:2278-2290.
15. 2 induces cell death in the cultured cortical neurons: a possible involvement of its binding sites. Brain Res 2002, 949:197-201.
16. 2 induces neuronal cell death via apoptosis. Mol Pharmacol 2002, 61:114-126.
17. 2 induces neuronal cell death via apoptosis. J Neurochem 2002, 81:449-461.
18. 2+ channels in cultured rat cortical neurons. J Neurochem 2003, 85:749-758.
19. 2+ channels. Brain Res 2003, 960:71-80.
20. 2 in plasma membranes from primary rat cortical neurons. Exp Cell Res 2003, 291:212-227.
21. 2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARgamma pathways. Biochem Biophys Res Commun 2011, 410:563-567.
22. 2 in neuronal plasma membrane. PLoS ONE 2011, 6:e17552.